Session » 4M090: Infection-Related Rheumatic Disease (1800–1805)
- 2:30PM-4:00PM
-
Abstract Number: 1801
Comparison of Infection-Related Hospitalization Risk and Cost in TNFi-Experienced Medicare Beneficiaries with Rheumatoid Arthritis Treated with Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs
- 2:30PM-4:00PM
-
Abstract Number: 1803
Performance of the RABBIT Infection Score in a Prospective Multicenter Cohort of Rheumatoid Arthritis Patients from Argentina
- 2:30PM-4:00PM
-
Abstract Number: 1805
Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 1800
Safety and Humoral Immunogenicity to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis (interim Analysis)
- 2:30PM-4:00PM
-
Abstract Number: 1804
Safety of the Zoster Vaccine Recombinant, Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center’s Experience with 400 Patients
- 2:30PM-4:00PM
-
Abstract Number: 1802
Utility of Repeat Latent Tuberculosis Testing in Patients Taking Biologics